1)- Bianca Weinstock-Guttman, Amy Perrin Ross, Jonathan Planton, Kurt White, Avni Pandhi, Andres Greco, Achint Kumar, Nicholas Everage, Megan Vignos. Analysis of Pregnancy Outcomes Following Exposure to Intramuscular Interferon Beta-1a: The AVONEX Pregnancy Exposure Registry.Drugs - real world outcomes. 2023, 10 (4): 503-511
3)- Hiromi Koshizuka, Kenji Momo, Ayako Watanabe, Airi Matsuzaki, Yuka Kashiwabara, Katsumi Tanaka, Bengt Lindholm, Tadanori Sasaki. Dilemma Facing Patients Aged 75 Years and Older on Fluid Restriction When Drug Package Inserts Advise Use of a Lot of Water: A Cross-Sectional, Descriptive, and Hypothesis-Generating Study Using a Large Claims Database.Drugs - real world outcomes. 2023, 10 (4): 521-529
4)- Elizabeth Marrett, Winghan Jacqueline Kwong, Jipan Xie, Ameur M Manceur, Selvam R Sendhil, Eric Wu, Raluca Ionescu-Ittu, Janakiraman Subramanian. Treatment Patterns and Adverse Event-Related Hospitalization Among Patients with Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non-small Cell Lung Cancer After Treatment with EGFR Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy Regimens.Drugs - real world outcomes. 2023, 10 (4): 531-544
5)- Ana Figueiredo, Ana Rodrigues, Carina Gaspar, Margarida Felizardo. Diagnosis and Treatment of Advanced ALK Rearrangement-Positive Non-Small-Cell Lung Cancer in Portugal: Results of a National Questionnaire.Drugs - real world outcomes. 2023, 10 (4): 545-555
6)- Joe F Wernicke, Tatsiana Verstak, Tianming Zhang, William Spalding, Laurie Lee, Yue Cheng, Alicia Ademi. Predictors of Pancreatitis Among Patients with Inflammatory Bowel Disease Treated with Vedolizumab: Observation from a Large Global Safety Database.Drugs - real world outcomes. 2023, 10 (4): 557-564
7)- Caroline Kelley Geiger, Daniel Sheinson, Tu My To, David Jones, Nicole Gidaya Bonine. Treatment Patterns by Race and Ethnicity in Newly Diagnosed Persons with Multiple Sclerosis.Drugs - real world outcomes. 2023, 10 (4): 565-575
8)- Waad Alghamdi, Nouf Al-Fadel, Eman A Alghamdi, Maha Alghamdi, Fawaz Alharbi. Signal Detection and Assessment of Herb-Drug Interactions: Saudi Food and Drug Authority Experience.Drugs - real world outcomes. 2023, 10 (4): 577-585
9)- Waad Alghamdi, Nouf Al-Fadel, Eman A Alghamdi, Maha Alghamdi, Fawaz Alharbi. Author Correction: Signal Detection and Assessment of Herb-Drug Interactions: Saudi Food and Drug Authority Experience.Drugs - real world outcomes. 2023, 10 (4): 587
10)- Alistair Ring, Meghan Karuturi, Emily Nash Smyth, Tasneem Lokhandwala, Kristin M Sheffield, Joanne Willey, Orsolya Lunacsek, Francisco Sapunar, Zhanglin Lin Cui, Anna D Coutinho, Sarah Rybowski. Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2- Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice.Drugs - real world outcomes. 2023, 10 (4): 589-603
11)- Kelly L Hayward, Rianne A Weersink, Christina M Bernardes, Carolyn McIvor, Tony Rahman, Richard Skoien, Paul J Clark, Katherine A Stuart, Gunter Hartel, Patricia C Valery, Elizabeth E Powell. Changing Prevalence of Medication Use in People with Cirrhosis: A Retrospective Cohort Study Using Pharmaceutical Benefits Scheme Data.Drugs - real world outcomes. 2023, 10 (4): 605-618
12)- Aylin N Satir, Miriam Pfiffner, Christoph R Meier, Angela Caduff Good. Prescribing Patterns in Pediatric General Wards and Their Association with Prescribing Errors: A Retrospective Observational Study.Drugs - real world outcomes. 2023, 10 (4): 619-629
13)- Kouken Hayashi. Efficacy of Three Teriparatide Preparations and Romosozumab, Osteogenesis Promoters, in the Treatment of Fresh Vertebral Fractures: A Retrospective Observational Study.Drugs - real world outcomes. 2023, 10 (4): 631-637
14)- Ieva Rutkovska, Andis Seilis, Zane Neikena, Elita Poplavska. Impact of Risk Minimisation Measures on Valproate Use among Women of Reproductive Age in Latvia Between 2013 and 2020: A 7-Year Nationwide Prescription Database Study.Drugs - real world outcomes. 2023, 10 (4): 639-649
15)- Daniel Andrés Hernández-Velásquez, Esteban Rodríguez-Martínez, Jhonathan David Montoya-Meneses, Juan Sebastián González-Ceballos, Katherin Mosquera-Pérez, Laura Patiño-Mazuera, Melissa González-Montoya, Andrés Gaviria-Mendoza, Jorge Enrique Machado-Alba. Clinical Characteristics and Treatment of Irritable Bowel Syndrome in a Colombian Population: A Cross-Sectional Study.Drugs - real world outcomes. 2023, 10 (4): 651-658
16)- Svetlana Garafola, Elizabeth Shiferaw, Vikram Dev. Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data.Drugs - real world outcomes. 2023, 10 (3): 351-356
17)- Khue Nguyen, Vinita Subramanya, Ambar Kulshreshtha. Risk Factors Associated With Polypharmacy and Potentially Inappropriate Medication Use in Ambulatory Care Among the Elderly in the United States: A Cross-Sectional Study.Drugs - real world outcomes. 2023, 10 (3): 357-362
18)- Aimée E M J H Linkens, Dennis Kurstjens, N Anne Zwietering, Vanja Milosevic, Kim P G M Hurkens, Noémi van Nie, Bob P A van de Loo, P Hugo M van der Kuy, Bart Spaetgens. Clinical Decision Support Systems in Hospitalized Older Patients: An Exploratory Analysis in a Real-Life Clinical Setting.Drugs - real world outcomes. 2023, 10 (3): 363-370
19)- Abdulrahman Kalash, Aly Abdelrahman, Ibrahim Al-Zakwani, Yousuf Al Suleimani. Potentially Harmful Drug-Drug Interactions and Their Associated Factors Among Hospitalized Cardiac Patients: A Cross-Sectional Study.Drugs - real world outcomes. 2023, 10 (3): 371-381
20)- Mulugeta Russom, Daniel Y B Jeannetot, Araia Berhane, Henok G Woldu, Bruno H Stricker, Katia M C Verhamme. Liver Injury Following Isoniazid Preventive Therapy in HIV Patients Attending Halibet National Referral Hospital, Eritrea: A Prospective Cohort Study.Drugs - real world outcomes. 2023, 10 (3): 383-394
21)- Afsaneh Barzi, Feng Lin, Jinlin Song, Clara Lam, Xiaoyu Nie, Ahmed Noman, Winghan J Kwong. Real-World Treatment Patterns and Economic Burden Following First-Line Trastuzumab in Patients with Metastatic Gastric Cancer in the USA.Drugs - real world outcomes. 2023, 10 (3): 395-404
22)- Toshiki Masuishi, Soshi Nagaoka, Long Jin, Kenichi Yoshizawa. Post-Marketing Safety Study of Ramucirumab Plus FOLFIRI: Analysis of Age and Initial Dose of Irinotecan in Patients with Metastatic Colorectal Cancer.Drugs - real world outcomes. 2023, 10 (3): 405-413
23)- Koichi Hirata, Mika Komori, Kaname Ueda, Anthony J Zagar, Yongin Kim, Dena H Jaffe, Yasuhiko Matsumori, Takao Takeshima. Outcomes and Factors Associated with Insufficient Effectiveness of Acute Treatments of Migraine in Japan: Results of the ObserVational survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study.Drugs - real world outcomes. 2023, 10 (3): 415-428
24)- Stephanie Korrer, April N Naegeli, Lida Etemad, Gabriel Johnson, Klaus T Gottlieb. Identifying Measures of Suboptimal Healthcare Interaction (SOHI) to Develop a Claims-Based Model for Predicting Patients with Inflammatory Bowel Disease at Risk for SOHI.Drugs - real world outcomes. 2023, 10 (3): 429-438
25)- Jingjun Wang, Mary E Ritchey, Kamika Reynolds, Madeleine Carbonneau, Adam Carrera, Noelia Goti, John R Horn, Cynthia J Girman. Assessment of Codispensing Patterns of Mirabegron and Prespecified CYP2D6 Substrates in Patients with Overactive Bladder.Drugs - real world outcomes. 2023, 10 (3): 439-446
26)- Dan Ouchi, Carles Vilaplana-Carnerero, Ramon Monfà, Maria Giner-Soriano, Ana Garcia-Sangenís, Ferran Torres, Rosa Morros. Impact of Second-Line Combination Treatment for Type 2 Diabetes Mellitus on Disease Control: A Population-Based Cohort Study.Drugs - real world outcomes. 2023, 10 (3): 447-457
27)- Beyene Dereje, Alemseged Workneh, Alemayehu Megersa, Shegaye Yibabie. Prescribing Pattern and Associated Factors in Community Pharmacies: A Cross-Sectional Study Using AWaRe Classification and WHO Antibiotic Prescribing Indicators in Dire Dawa, Ethiopia.Drugs - real world outcomes. 2023, 10 (3): 459-469
28)- Dee Lin, Dominic Pilon, Laura Morrison, Aditi Shah, Marie-Hélène Lafeuille, Patrick Lefebvre, Carmela Benson. A Cross-Sectional Study of Patient Out-of-Pocket Costs for Antipsychotics Among Medicaid Beneficiaries with Schizophrenia.Drugs - real world outcomes. 2023, 10 (3): 471-480
29)- Yuichi Uwai, Tomohiro Nabekura. Data Mining for Risks of Clozapine Side Effects, Including Neutropenia, Associated with Lithium Carbonate Administration: Analysis Using the Japanese Adverse Drug Event Report Database.Drugs - real world outcomes. 2023, 10 (3): 481-489
30)- Khedidja Hedna, Margda Waern. Use of Psychoactive Medications and Risk of Suicide in Late Life (75+): A Total Population Study.Drugs - real world outcomes. 2023, 10 (3): 491-498
31)- Thomas Laurent, Dimitra Lambrelli, Ryozo Wakabayashi, Takahiro Hirano, Ryohei Kuwatsuru. Strategies to Address Current Challenges in Real-World Evidence Generation in Japan.Drugs - real world outcomes. 2023, 10 (2): 167-176
32)- Michel Bouchoucha, Caroline Amand, Beatrice Bois De Fer, Robert Lange. A Retrospective Real-World Observational Study Assessing the Evolution of Bisacodyl Prescriptions in Patients with Constipation During Long-Term Treatment.Drugs - real world outcomes. 2023, 10 (2): 249-261
33)- Bahia Chahine. Drug Burden Index in Older Adults with Psychiatric Illnesses: A Cross-Sectional Study.Drugs - real world outcomes. 2023, 10 (2): 283-290
34)- Amanda L Banaag, Harvey B Pollard, Tracey P Koehlmoos. Digoxin and Standard-of-Care Therapy for Heart Failure Patients with COVID-19: Analysis of Data from the US Military Health System (MHS) Data Repository.Drugs - real world outcomes. 2023, 10 (2): 299-307
35)- Gérard Reach, Aurélie Calvez, Nanthara Sritharan, Marouane Boubaya, Vincent Lévy, Stéphanie Sidorkiewicz, May Fiani. Patients' Perceived Importance of Medication and Adherence in Polypharmacy, a Quantitative, Cross-Sectional Study Using a Questionnaire Administered in Three Doctors' Private Practices in France.Drugs - real world outcomes. 2023, 10 (2): 309-320
36)- Shotaro Kobayashi, Norio Sugama, Hiroyuki Nagano, Ayaka Miyamori, Masahiro Takahashi, Akifumi Kushiyama. Analysis of Adverse Events of Cholinesterase Inhibitors and NMDA Receptor Antagonists on Arrhythmias Using the Japanese Adverse Drug Event Report Database.Drugs - real world outcomes. 2023, 10 (2): 321-329
37)- Kazutaka Nozawa, Yingsong Lin, Nozomi Ebata, Ryozo Wakabayashi, Takahiro Ushida, Masataka Deie, Shogo Kikuchi. Perioperative Analgesics and Anesthesia as Risk Factors for Postoperative Chronic Opioid Use in Patients Undergoing Total Knee Arthroplasty: A Retrospective Cohort Study Using Japanese Hospital Claims Data.Drugs - real world outcomes. 2023, 10 (2): 331-340
38)- Porapong Petch-In, Surasak Saokaew, Pochamana Phisalprapa, Piyameth Dilokthornsakul. The Association of Pre-operative Serum Albumin Levels and Post-operative In-Hospital Death in Patients Undergoing Gastrointestinal Surgeries in Thailand: A Retrospective Cohort Study.Drugs - real world outcomes. 2023, 10 (2): 341-349
40)- Charmi Patel, Seth Emont, Zhun Cao, Manu Tyagi, Carmela Benson. Post Hospitalization Clinical Quality Outcomes Among US Patients with Schizophrenia Treated with a Long-Acting Injectable or Switched to a New Oral Antipsychotic: A Retrospective Cohort Study.Drugs - real world outcomes. 2023, :
42)- Corrado Giua, Flora Romano, Enrico Keber, Paolo Pellegrino, Marcos Perez, Maria Chiara Uboldi, . A Prospective Real-World Study of Bacillus clausii Evaluating Use, Treatment Habits and Patient Satisfaction in Italian Community Pharmacies: The PEGASO Study.Drugs - real world outcomes. 2023, :
43)- Maaja Ivask, Katrin Kurvits, Maia Uusküla, Anne Juppo, Ott Laius, Mia Siven. Compliance with Pregnancy Prevention Recommendations for Isotretinoin Following the Amendment of the European Union Pregnancy Prevention Program: A Repeat Study in Estonia.Drugs - real world outcomes. 2023, :
44)- Hiroyuki Hashimoto, Shinobu Imai, Ryoka Yamashita, Anna Kiyomi, Munetoshi Sugiura. Association of Antipsychotic Drugs with the Risk of Recurrent Venous Thromboembolism: A Retrospective Study of Data from a Japanese Inpatient Database.Drugs - real world outcomes. 2023, :
45)- Joanne Man-Wai Ho, Eric To, Rebecca Sammy, Matei Stoian, Jennifer Man-Han Tung, Robert Jack Bodkin, Lindsay Cox, Tony Antoniou, Sophiya Benjamin. Outcomes of a Medication Optimization Virtual Interdisciplinary Geriatric Specialist (MOVING) Program: A Feasibility Study.Drugs - real world outcomes. 2023, :
46)- E Lyn Lee, Jeff Harrison, Joanne Barnes. Exploring the Use of Traditional Medicines, Natural Health Products and Conventional Medicines: Development and Testing of the New Zealand 'All-Medicines' Questionnaire.Drugs - real world outcomes. 2023, :
47)- Dennis Steenhuis, Xuechun Li, Talitha Feenstra, Eelko Hak, Stijn de Vos. The Association between Deductibles and Cardiovascular Medication Adherence: A Retrospective Inception Cohort Study.Drugs - real world outcomes. 2023, :
48)- Maria Maddalena Nicoletti, Erminia Crisci, Vincenzo Cosenza, Consiglia Riccardi, Maria Rosaria Campitiello, Donatella Ruggiero, Pasquale Maria Berrino, Giovanni Docimo, Cristina Scavone. Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database.Drugs - real world outcomes. 2023, :
49)- Bipin Sethi, Rakesh Sahay, Mangesh Tiwaskar, Vijay Negalur, Rajnish Dhediya, Kumar Gaurav, Rahul Rathod, Bhavesh Kotak, Gauri Dhanaki, Snehal Shah. Effectiveness of Dapagliflozin as Add-On to Metformin with or without Other Oral Antidiabetic Drugs in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Database Study.Drugs - real world outcomes. 2023, :
50)- Kotaro Iwasaki, Hiroki Wakabayashi, Atsuhito Saiki, Hajime Ueshiba, Yu Murakami, Yasuo Matsuzawa. Real-World Clinical Efficacy of Antifibrotic Agents for Idiopathic Pulmonary Fibrosis: A Single-Center Retrospective Study in Japan.Drugs - real world outcomes. 2023, :